Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAR | ANAB | ABCL | ||
| Company | Pharming Group N.V. ADR | Anaptysbio Inc | Abcellera Biologics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 17.75 | 45.78 | 4.15 | ||
| High | 18.33 | 46.80 | 4.30 | ||
| Low | 17.35 | 44.44 | 4.05 | ||
| Latest | 17.92 | 46.68 | 4.28 | ||
| Change | unch | +0.47 | +0.12 | ||
| % Change | unch | +1.02% | +2.88% | ||
| Volume | 19,100 | 216,000 | 3,892,200 | ||
| 20-Day Average Volume | 28,122 | 509,345 | 4,487,890 | ||
| Previous Close | 17.92 | 46.21 | 4.16 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 17.74 | 47.31 | 3.91 | ||
| 20-Day Raw Stochastic | 54.80% | 44.70% | 71.21% | ||
| 20-Day Relative Strength | 53.64 | 54.12 | 56.82 | ||
| Weighted Alpha | +102.38 | +133.00 | +23.21 | ||
| Today's Opinion | 100% Buy | 88% Buy | 8% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 8% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.55% since 01/13/26 | -3.00% since 01/13/26 | +0.23% since 01/13/26 | ||
| Low | 17.25 on 01/20/26 | 44.25 on 01/20/26 | 3.92 on 01/20/26 | ||
| High | 18.72 on 01/14/26 | 50.50 on 01/15/26 | 4.38 on 01/16/26 | ||
| 1-Month | |||||
| %Chg | +7.82% since 12/19/25 | -4.89% since 12/19/25 | +18.89% since 12/19/25 | ||
| Low | 16.55 on 01/06/26 | 42.00 on 01/06/26 | 3.34 on 01/02/26 | ||
| High | 19.05 on 01/12/26 | 52.47 on 12/29/25 | 4.66 on 01/12/26 | ||
| 3-Month | |||||
| %Chg | +32.06% since 10/21/25 | +36.85% since 10/21/25 | -23.30% since 10/21/25 | ||
| Low | 12.68 on 11/05/25 | 30.27 on 11/10/25 | 3.32 on 12/17/25 | ||
| High | 19.05 on 01/12/26 | 52.47 on 12/29/25 | 5.97 on 10/24/25 | ||
| 6-Month | |||||
| %Chg | +75.26% since 07/21/25 | +78.37% since 07/21/25 | -16.89% since 07/21/25 | ||
| Low | 9.54 on 07/30/25 | 17.11 on 09/16/25 | 3.32 on 12/17/25 | ||
| High | 19.05 on 01/12/26 | 52.47 on 12/29/25 | 6.51 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,256,909 | 1,279,462 | 1,245,234 | ||
| Shares Outstanding, K | 70,140 | 27,688 | 299,335 | ||
| Annual Sales | 297,200,000 | 91,280,000 | 28,830,000 | ||
| Annual Net Income | -11,840,000 | -145,230,000 | -162,860,000 | ||
| Last Quarter Sales | 97,300,000 | 76,320,000 | 8,960,000 | ||
| Last Quarter Net Income | 7,500,000 | 15,110,000 | -57,120,000 | ||
| 60-Month Beta | 0.00 | 0.32 | 0.73 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.10 on 11/06/25 | 0.52 on 11/04/25 | -0.19 on 11/06/25 | ||
| Latest Earnings Date | 03/12/26 | 02/26/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||